HUMAN/HUMAN HYBRIDOMA TO PRODUCE HUMAN IMMUNO-GLOBULIN OF ANTIGENIC SPECIFICITY RELATED TO CANCER
NEW MATERIAL:A human immunoglobulin of antigen specificity produced by a human/human fusion cell strain of human B-cell of human stomach cancer patient and a subclone of a human lymphoblast cell strain. USE:A drug for preventing, remedying and diagnosing human lung cancer, brain tumor, malignant mel...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | NEW MATERIAL:A human immunoglobulin of antigen specificity produced by a human/human fusion cell strain of human B-cell of human stomach cancer patient and a subclone of a human lymphoblast cell strain. USE:A drug for preventing, remedying and diagnosing human lung cancer, brain tumor, malignant melanoma, etc. PREPARATION:For example, a B-cell from a lymph node in the periphery of cancerous tissue collected in the operation of a stomach cancer patient and a subclone of a human lymphoblast cell strain are subjected to cell fusion in the presence of polyethylene glycol and cultivated in HAT medium, to give a hybridoma. Then, it is cloned by limiting dilution, etc., made into a monoclone, cultivated in a medium and a product is purified, to give a monoclonal antibody. |
---|